On May 21, 2025, Primrose Bio participated in the Antibody Engineering & Therapeutics Spring Digital Week, a virtual event hosted in collaboration with The Antibody Society. Russell Coleman delivered a featured presentation titled “Pfast™ Protein Expression: A Rapid, Robust Solution,” highlighting the capabilities of our P. fluorescens–based Pfenex Expression Technology®.
Backed by more than 20 years of development and proven across six marketed products, Pfenex enables efficient protein production through combinatorial screening. In 2024, we launched Pfast™, a 10-day evaluation program designed to rapidly assess protein titer and quality. With over 30 partner proteins tested, Pfast has consistently helped improve productivity bottlenecks and streamline development pipelines.
